Apomorphine
- PDF / 169,046 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 41 Downloads / 150 Views
1 S
Immune haemolytic anaemia: case report A male patient [specific age not stated] developed immune haemolytic anaemia during treatment with apomorphine for severe parkinsonism. The male patient, who had severe parkinsonism, had been treated with high-dose levodopa [L-dopa], which was currently switched to apomorphine [dosage and route not stated]. During the early stages of apomorphine administration in the ICU, he developed jaundice and pallor. Further investigations revealed apomorphine-induced immune haemolytic anaemia [duration of treatment to reaction onset not stated]. His apomorphine therapy was discontinued [outcome not stated]. Esmaeili S, et al. Apomorphine induced immune hemolytic anemia. Journal of the Neurological Sciences 405 (Suppl.): 249, 15 Oct 2019. Available from: URL: http:// 803445989 doi.org/10.1016/j.jns.2019.10.1274 [abstract]
0114-9954/20/1787-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 18 Jan 2020 No. 1787
Data Loading...
